Yusuf Açıkgöz
YOU?
Author Swipe
View article: POS0344-HPR IS IT FEAR OR PAIN UNDERSTANDING IT'S IMPACT ON PHYSICAL PERFORMANCE AND RUMINATION IN CHILDREN WITH RHEUMATIC DISEASES
POS0344-HPR IS IT FEAR OR PAIN UNDERSTANDING IT'S IMPACT ON PHYSICAL PERFORMANCE AND RUMINATION IN CHILDREN WITH RHEUMATIC DISEASES Open
View article: POS1485-HPR PHYSICAL FITNESS TRAFFIC LIGHTS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND FAMILIAL MEDITERRANEAN FEVER: A FITNESSGRAM ROADMAP
POS1485-HPR PHYSICAL FITNESS TRAFFIC LIGHTS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND FAMILIAL MEDITERRANEAN FEVER: A FITNESSGRAM ROADMAP Open
View article: OP0379-HPR Tracking Step Counts in Adolescents with Juvenile Idiopathic Arthritis and Familial Mediterranean Fever: A 3-Month m-Health Monitoring Study Using Smartwatches
OP0379-HPR Tracking Step Counts in Adolescents with Juvenile Idiopathic Arthritis and Familial Mediterranean Fever: A 3-Month m-Health Monitoring Study Using Smartwatches Open
View article: Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma
Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma Open
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. HCC treatment is challenging; surgical resection is the primary curative treatment for early-stage disease, but recurrence rates are high. Immune checkpoint inhibitors…
View article: Impact of <sup>68</sup>Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
Impact of <sup>68</sup>Ga-PSMA PET/CT on Survival and Management in Prostate Cancer Open
Background:: 68Ga-labeled prostate-specific membrane antigen positron emission tomography-computed tomography (68Ga-PSMA PET/CT) has led to altered treatment plans for prostate cancer (PCa) patients. Objective:: This study aimed to investi…
View article: Issue Information
Issue Information Open
The IeDEA West Africa Collaboration HIV favours the persistence of high-risk HPV and progression of cervical intraepithelial neoplasia to cancer, with universal access to antiretroviral therapy also possibly influencing high-risk HPV distr…
View article: Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options
Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options Open
Non‐clear cell renal cell carcinoma (nccRCC) makes up nearly one quarter of all RCC subtypes, commonly impacts younger patients, and is often metastatic at presentation. Compared to clear‐cell RCC (ccRCC), nccRCC typically has a worse prog…
View article: Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data
Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data Open
Male gender, poor performance status, grade 3 tumor, MLNR > 0.37, and not receiving adjuvant chemotherapy are predictors of poor prognosis in N3 gastric cancer after curative resection. Considering the high recurrence rates of this group, …
View article: The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience
The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience Open
Aims and Background: In general, neoadjuvant treatment is the standard for clinical stage II/III esophageal cancer (EC), whereas the effect of adjuvant treatment on survival still remains controversial. The aim of this study was to investi…
View article: Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index
Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index Open
Background: Inflammation markers are the new point of view in cancer due to increasing data on the interaction of immune system with tumor cells and their prognostic and predictive importance were found in many different types of solid tum…
View article: First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma Open
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be…
View article: 120P Efficacy of postoperative radiotherapy (PORT) in stage IIIA-N2 non-small cell lung cancer: Meta-analysis of randomized controlled studies
120P Efficacy of postoperative radiotherapy (PORT) in stage IIIA-N2 non-small cell lung cancer: Meta-analysis of randomized controlled studies Open
View article: Nutritional Health in Premenopausal Women: A Cross-Sectional Study from Turkey
Nutritional Health in Premenopausal Women: A Cross-Sectional Study from Turkey Open
Background: The aim of this study was to evaluate the nutritional habits of premenopausal women using the Food Consumption Frequency Questionnaire (FCFQ) and to evaluate the relationship between anthropometric measurements, lipid parameter…
View article: Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients
Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients Open
Introduction:In this article, it is aimed to present the clinicopathological and demographic characteristics, treatment regimens and survival characteristics of locally advanced tongue squamous cell cancers (TSCC).Materials and methods: Th…
View article: An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience
An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience Open
Objective: Although germ cell tumors (GCT) are rare malignancies, they are the most common solid tumors in men aged 15-40 years.This study aimed to compare the demographic and clinical characteristics, treatment responses, and survival cha…
View article: P-85 Relationship between microsatellite instability and neoadjuvant chemotherapy response in gastric or gastroesophageal junction cancer: A meta-analysis
P-85 Relationship between microsatellite instability and neoadjuvant chemotherapy response in gastric or gastroesophageal junction cancer: A meta-analysis Open
View article: The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer
The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer Open
View article: Efficacy and Safety of Neoadjuvant Immunotherapy in Triple Negative Breast Cancer: Meta-analysis of randomized controlled trials
Efficacy and Safety of Neoadjuvant Immunotherapy in Triple Negative Breast Cancer: Meta-analysis of randomized controlled trials Open
Aim: In this meta-analysis; The efficacy and safety of randomized controlled trials (RCTs) using immunotherapy in the neoadjuvant treatment of triple negative breast cancer were investigated. Material and Method: To determine the studies t…
View article: “Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?
“Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave? Open
View article: The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer
The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer Open
Stage III non-small cell lung cancer (NSCLC) is a highly heterogeneous subtype of lung cancer. There are still no widely accepted prognostic parameters for stage III NSCLC. In this study, we evaluated the prognostic value of the standardiz…
View article: Systemic treatment options for growing teratoma syndrome
Systemic treatment options for growing teratoma syndrome Open
Background: Growing teratoma syndrome (GTS) is a very uncommon phenomena. Given its lower prevalence, there is little data about clinichopathological features and management of GTS. Literature about disease mostly composed of case reports.…
View article: Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer Open
Colorectal cancer (CRC) is the third most common cancer in the world and is the second leading cause of cancer-related deaths. Several mutations are involved in the development of CRC. The prognostic significance of the KRAS mutation has b…
View article: Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? Open
View article: HER2-POZİTİF LOKAL İLERİ MEME KANSERİNDE NEOADJUVAN TRASTUZUMAB SIRALAMASININ PATOLOJİK TAM YANIT ÜZERİNE ETKİSİ The effect of neoadjuvant trastuzumab treatment sequence on pathologic complete response in HER2-positive locally advanced breast cancer
HER2-POZİTİF LOKAL İLERİ MEME KANSERİNDE NEOADJUVAN TRASTUZUMAB SIRALAMASININ PATOLOJİK TAM YANIT ÜZERİNE ETKİSİ The effect of neoadjuvant trastuzumab treatment sequence on pathologic complete response in HER2-positive locally advanced breast cancer Open
Amaç: Trastuzumabın meme kanserinde neoadjuvan tedaviye eklenmesiyle patolojik tam yanıt (PTY) oranınıarttırdığı bilinmektedir. Ancak trastuzumabın kullanım sırasıyla ilgili kısıtlı veri bulunmaktadır. HER2 pozitiflokal ileri meme kanserin…
View article: Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer? Open
PTR did not offer an overall survival benefit in this study. Although it is debated, we think that it is better to start treatment with chemotherapy and biological agent combinations in patients with asymptomatic mCRC. Thus, the patients c…
View article: Characteristics of Patients Who Received Chemotherapy During The Covid 19 Pandemic and Changes in Oncology Practice
Characteristics of Patients Who Received Chemotherapy During The Covid 19 Pandemic and Changes in Oncology Practice Open
ÖZET GİRİŞ ve AMAÇ: Koronavirüs hastalığı 2019 (Covid 19) pandemi şartlarında, pandemi merkezinde sorunsuz bir şekilde kemoterapi alan hastaların özelliklerinin belirlenmesi
View article: The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients
The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients Open
BACKGROUND: There are different data in the literature about the consequences of the development of metastasis as de novo or recurrent. In this study, we retrospectively investigated the clinicopathologic and prognostic characteristics of …
View article: Albumin to alkaline phosphatase ratio: does it predict survival in grade 1 and grade 2 neuroendocrine tumors?
Albumin to alkaline phosphatase ratio: does it predict survival in grade 1 and grade 2 neuroendocrine tumors? Open
The authors have withdrawn the journal submission associated with this preprint and requested that the preprint also be withdrawn.
View article: Albumin to alkaline phosphatase ratio: does it predict survival in grade 1 and grade 2 neuroendocrine tumors?
Albumin to alkaline phosphatase ratio: does it predict survival in grade 1 and grade 2 neuroendocrine tumors? Open
BACKGROUND: Neuroendocrine tumors (NETs) are very heterogeneous tumors. Although it is classified according to Ki-67 proliferation index and mitotic count, their behavior may greatly vary even in the same group. Therefore, more accurate pr…
View article: Is There a Novel Prognostic Parameter for Well-Differentiated Neuroendocrine Tumours? The Prognostic Value of Albumin and Hemoglobin in Patients Well-Differentiated Neuroendocrine Tumours
Is There a Novel Prognostic Parameter for Well-Differentiated Neuroendocrine Tumours? The Prognostic Value of Albumin and Hemoglobin in Patients Well-Differentiated Neuroendocrine Tumours Open
BACKGROUND: Neuroendocrine tumours (NETs) are a heterogeneous group of tumours. There are no well-established prognostic factors for accurately predicting survival of patients with well-differentiated NETs. Prognostic value of inflammatory…